Anti-Granzyme K antibody [EPR24601-164]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Anti-Granzyme K antibody [EPR24601-164] (ab282703) is a rabbit monoclonal antibody detecting Granzyme K in Western Blot, IHC-P. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
TRYP2, GZMK, Granzyme K, Fragmentin-3, Granzyme-3, NK-tryptase-2, NK-Tryp-2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Granzyme K antibody [EPR24601-164] (AB282703)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labelling Granzyme K with ab282703 at 1/1000 dilution (0.485 ug/ml), followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human tonsil. (PMID : 22207739). The section was incubated with ab282703 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Granzyme K antibody [EPR24601-164] (AB282703)
Immunohistochemical analysis of paraffin-embedded human cervical carcinoma tissue labelling Granzyme K with ab282703 at 1/1000 dilution (0.485 ug/ml), followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used. Positive staining on immune cells of human cervical carcinoma. The section was incubated with ab282703 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Granzyme K antibody [EPR24601-164] (AB282703)
Immunohistochemical analysis of paraffin-embedded human diffuse large B-cell lymphoma tissue labelling Granzyme K with ab282703 at 1/1000 dilution (0.485 ug/ml), followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used. Positive staining on human diffuse large B-cell lymphoma. The section was incubated with ab282703 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Granzyme K antibody [EPR24601-164] (AB282703)
Immunohistochemical analysis of paraffin-embedded human NKT lymphoma tissue labelling Granzyme K with ab282703 at 1/1000 dilution (0.485 ug/ml), followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human NKT lymphoma. The section was incubated with ab282703 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Granzyme K antibody [EPR24601-164] (AB282703)
Immunohistochemical analysis of paraffin-embedded human pancreas tissue labelling Granzyme K with ab282703 at 1/1000 dilution (0.485 ug/ml), followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Negative control : no staining on human pancreas. The section was incubated with ab282703 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Granzyme K antibody [EPR24601-164] (AB282703)
Immunohistochemical analysis of paraffin-embedded human endometrium tissue labelling Granzyme K with 282703 at 1/1000 dilution (0.485 ug/ml), followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on lymphocytes in human endometrium. The section was incubated with ab282703 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- WB
Lab
Western blot - Anti-Granzyme K antibody [EPR24601-164] (AB282703)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The expression profile/molecular weight observed is consistent with what has been described in the literature (PMID : 10407175, 18559365).
Negative control : heart (PMID : 10407175).
Exposure time : 15 seconds
All lanes:
Western blot - Anti-Granzyme K antibody [EPR24601-164] (ab282703) at 1/1000 dilution
Lane 1:
Human spleen tissue lysate at 40 µg
Lane 2:
Human tonsil tissue lysate at 40 µg
Lane 3:
Human lymphoma tissue lysate at 40 µg
Lane 4:
Human heart tissue lysate at 40 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/2000 dilution
Predicted band size: 29 kDa
Observed band size: 22 kDa,27 kDa
false
Related conjugates and formulations (1)
-
Anti-Granzyme K antibody [EPR24601-164] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-Granzyme K antibody [EPR24601-164] (ab282703) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human samples.
What is the molecular weight of Granzyme K?
Anti-Granzyme K [EPR24601-164] (ab282703) specifically detects a band for Granzyme K (UniProt: P49863) at a molecular weight of 29kDa.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR24601-164] also available for your convenience: ab282703, Carrier free - ab282714
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Granzyme K serves as a potent mediator in the immune system by inducing apoptosis in target cells. It does not act alone but rather in concert with other granzymes and proteins to effectively execute cell death. Granzyme K can degrade cellular proteins once introduced into a target cell's cytoplasm leading to apoptosis. The protease functions independently and does not require a complex for its activity contributing to the immune system's ability to eliminate infected or transformed cells.
Pathways
The granzyme K protein exists within essential immune regulatory pathways such as the cytotoxic T lymphocyte-induced apoptosis pathway and the natural killer cell-mediated cytotoxicity pathway. Granzyme K acts alongside granzymes A and B to promote programmed cell death and finely tune host immune responses. While granzymes A and B have more defined roles granzyme K complements their activity offering redundancy and ensuring efficient elimination of harmful target cells.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
World journal of diabetes 16:109553 PubMed40980297
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular gastroenterology and hepatology 19:101411 PubMed39349248
2024
Applications
Unspecified application
Species
Unspecified reactive species
NPJ precision oncology 8:159 PubMed39060379
2024
Applications
Unspecified application
Species
Unspecified reactive species
Environmental toxicology 39:890-904 PubMed37956258
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com